发明名称 Insulin-mimetic local therapeutic adjuncts for enhancing spinal fusion
摘要 <p>Bone tissue materials comprising insulin-mimetic agents, such as suitable zinc, vanadium, tungsten, molybdenum, niobium, selenium, and manganese compounds, for facilitating spinal fusion of vertebrae in spinal fusion surgical procedures, and methods thereof. Additionally provided is a bone tissue kit for facilitating fusion of vertebrae in a spinal fusion surgical procedure including a composition formulated for facile application in a spinal fusion procedure comprising an insulin-mimetic agent and a pharmaceutically acceptable carrier. Yet further provided is an implantable device for enhancing spinal fusion including a prosthetic implant configured to stabilize and promote the fusion of two adjacent vertebrae, wherein the bone tissue contacting surfaces of the prosthetic implant are coated with a composition comprising an insulin-mimetic agent.</p>
申请公布号 AU2013334111(A1) 申请公布日期 2015.05.28
申请号 AU20130334111 申请日期 2013.10.25
申请人 RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 发明人 LIN, SHELDON SUTON;KOERNER, JOHN;VIVES, MICHAEL J.;BENEVENIA, JOSEPH;BREITBART, ERIC
分类号 A61F2/30;A61F2/44;A61F2/46;A61K35/32;A61K38/28;C12N15/17 主分类号 A61F2/30
代理机构 代理人
主权项
地址